Jushi Holdings Inc.

JUSHF

OTC

Healthcare

Drug Manufacturers - Specialty & Generic

Boca Raton, FL, US1,234 employeesjushico.com

—

At a Glance

AI-generated

Jushi Holdings delivered modest revenue growth in FY2025, but profitability and cash flow metrics declined significantly due to higher interest costs, tax provisions, and margin compression in a challenging competitive environment.

Revenue breakdown: Retail Cannabis (89%), Wholesale Cannabis (11%).

8-K

Jushi Holdings Inc. reported Q4 2025 revenue of $68.3 million and full year revenue of $262.9 million, with Adjusted EBITDA margins expanding to 20.4% and 19.1%, alongside post-year-end debt refinancing extending maturities to 2029.

—

Market Cap

—

Revenue

—

Net Income

Employees1,234

Fundamentals

How The Business Makes Money

Revenue by Segment

Retail Cannabis89%($703M)

Wholesale Cannabis11%($87M)

Activity

What Changed Recently

Management Change

Jan 5, 2026

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Entry into CEO

Financial Results

Mar 30, 2026

, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 (the “Section”) of the Securities Exchange Act of 1934,

Peer Companies

Company	Price	Change	Market Cap	P/E
RCELAVITA Medical, Inc.	$3.69	-2.25%	$92M	-2.5
CBWTFAuxly Cannabis Group Inc.	—	—	—	—
VTIAFFamiCord AG	—	—	—	—
ORXOFOrexo AB (publ)	—	—	—	—
AAWHAscend Wellness Holdings,...	—	—	—	—
HLTRFHLS Therapeutics Inc.	—	—	—	—
ORXOYOrexo AB (publ)	—	—	—	—
SHIEFShield Therapeutics plc	—	—	—	—

Analyst View

Company Profile

CIK0001909747

ISINCA48213Y1079

CUSIP48213Y107

Phone888 498 8842

Address301 Yamato Road, Boca Raton, FL, 33431, US

SEC EDGAR